GOOD DAY FOR: A drug war, as Pfizer, the world’s largest drugmaker, is considering a counteroffer for Indian generics giant Ranbaxy Laboratories, the Business Standard newspaper reported. Japan’s Daiichi Sankyo bid $4.6 billion for Ranbaxy earlier this week. A Ranbaxy spokesman called the report “speculation,” adding, “We have a binding contract with Daiichi. It is a final contract.” (Reuters)
BAD DAY FOR: Overpacking, after United Airlines and US Airways both said they will charge $15 for passengers’ first checked bag, following American Airlines’ lead. Most U.S. airlines, except for Southwest, already charge $25 for checking a second piece of luggage. US Airways also said it will cut 1,700 jobs, shrink its fleet, and start charging for all in-flight beverages. (AP in Yahoo! Finance)
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Mickey 17: 'charming space oddity' that's a 'sparky one-off'The Week Recommends 'Remarkable' Robert Pattinson stars in Bong Joon-ho's sci-fi comedy
-
EastEnders at 40: are soaps still relevant?Talking Point Albert Square's residents are celebrating, but falling viewer figures have fans worried the soap bubble has burst
-
What will the thaw in Russia-US relations cost Europe?Today's Big Question US determination to strike a deal with Russia over Ukraine means Europe faces 'betrayal by a long-term ally'
